Literature DB >> 23943190

Electroencephalography in pediatric moyamoya disease: reappraisal of clinical value.

Anna Cho1, Jong-Hee Chae, Hun Min Kim, Byung Chan Lim, Hee Hwang, Yong Seung Hwang, Ji Hoon Phi, Seung-Ki Kim, Kyu-Chang Wang, Byung-Kyu Cho, Ki Joong Kim.   

Abstract

PURPOSE: The clinical value of electroencephalography (EEG) in pediatric moyamoya disease has been underestimated, though the characteristic patterns are well known. We undertook this study to evaluate the clinical value of EEG as a diagnostic and postoperative follow-up modality in pediatric moyamoya disease.
METHODS: We retrospectively reviewed the pre and postoperative EEG with effective hyperventilation in 127 pediatric moyamoya patients and compared their patterns with hemodynamic images.
RESULTS: One hundred and two patients (80.3 %) among 127 showed abnormal EEG findings before revascularization surgery. The typical rebuild-up phenomenon was observed in 82 (64.6 %) and localized build-up in 32 (25.2 %) without any significant clinical ischemic events during and after hyperventilation. The rebuild-up was observed more frequently in younger age groups (less than 13 years) and Suzuki stages III. The location of the rebuild-up distribution and asymmetric build-up was consistent with the area showing hemodynamic abnormalities on single photon emission computed tomography and/or perfusion magnetic resonance imaging. Postoperative follow-up EEGs were performed in 41 patients. Six patients with remaining rebuild-up in postoperative follow-up EEG showed poorer postoperative clinical outcomes.
CONCLUSIONS: This study may reappraise EEG as an easy, safe, and adjunctive diagnostic and postoperative follow-up modality for evaluation of hemodynamic status and clinical outcome, especially in children with moyamoya disease.

Entities:  

Mesh:

Year:  2013        PMID: 23943190     DOI: 10.1007/s00381-013-2215-4

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  30 in total

Review 1.  Moyamoya disease: current concepts and future perspectives.

Authors:  Satoshi Kuroda; Kiyohiro Houkin
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

2.  Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo(periosteal)synangiosis in pediatric moyamoya disease.

Authors:  Seung-Ki Kim; Kyu-Chang Wang; In-One Kim; Dong Soo Lee; Byung-Kyu Cho
Journal:  Neurosurgery       Date:  2002-01       Impact factor: 4.654

3.  Cerebral revascularization for moyamoya disease in children.

Authors:  K Houkin; S Kuroda; N Nakayama
Journal:  Neurosurg Clin N Am       Date:  2001-07       Impact factor: 2.509

4.  Electroencephalogram monitoring during intracranial surgery for moyamoya disease.

Authors:  Martina Vendrame; Joseph Kaleyias; Tobias Loddenkemper; Ed Smith; Craig McClain; Mark Rockoff; Sheryl Manganaro; Bonnie McKenzie; Lixia Gao; Michael Scott; Blaise Bourgeois; Sanjeev V Kothare
Journal:  Pediatr Neurol       Date:  2011-06       Impact factor: 3.372

5.  Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey.

Authors:  K Wakai; A Tamakoshi; K Ikezaki; M Fukui; T Kawamura; R Aoki; M Kojima; Y Lin; Y Ohno
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

6.  Moyamoya disease: diagnostic accuracy of MRI.

Authors:  I Yamada; S Suzuki; Y Matsushima
Journal:  Neuroradiology       Date:  1995-07       Impact factor: 2.804

7.  Encephaloduroarteriosynangiosis with bifrontal encephalogaleo(periosteal)synangiosis in the pediatric moyamoya disease: the surgical technique and its outcomes.

Authors:  Chae-Yong Kim; Kyu-Chang Wang; Seung-Ki Kim; You-Nam Chung; Hee-Soo Kim; Byung-Kyu Cho
Journal:  Childs Nerv Syst       Date:  2003-05-13       Impact factor: 1.475

8.  Hyperventilation induced abnormalities in the electroencephalogram of children with Moyamoya disease.

Authors:  T R Sunder; C W Erwin; P J Dubois
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1980-08

9.  Evaluation of cerebral hemodynamics with perfusion MRI in childhood moyamoya disease.

Authors:  Seung-Ki Kim; Kyu-Chang Wang; Chang-Wan Oh; In-One Kim; Dong Soo Lee; In Chan Song; Byung-Kyu Cho
Journal:  Pediatr Neurosurg       Date:  2003-02       Impact factor: 1.162

10.  Childhood moyamoya disease: quantitative evaluation of perfusion MR imaging--correlation with clinical outcome after revascularization surgery.

Authors:  Tae Jin Yun; Jung-Eun Cheon; Dong Gyu Na; Woo Sun Kim; In-One Kim; Kee-Hyun Chang; Kyung Mo Yeon; In Chan Song; Kyu-Chang Wang
Journal:  Radiology       Date:  2009-04       Impact factor: 11.105

View more
  6 in total

1.  Delayed posterior circulation insufficiency in pediatric moyamoya disease.

Authors:  Ji Yeoun Lee; Young-Hun Choi; Jung-Eun Cheon; Jin Chul Paeng; Hye Won Ryu; Ki Joong Kim; Ji Hoon Phi; Kyu-Chang Wang; Byung-Kyu Cho; Jong-Hee Chae; Seung-Ki Kim
Journal:  J Neurol       Date:  2014-09-12       Impact factor: 4.849

2.  Changes in Brain Functional Network Connectivity in Adult Moyamoya Diseases.

Authors:  Gaoxing Zheng; Yu Lei; Yuzhu Li; Wei Zhang; Jiabin Su; Xiaoying Qi; Liang Chen; Xin Zhang; Yuxiang Gu; Yuguo Yu; Ying Mao
Journal:  Cogn Neurodyn       Date:  2021-02-07       Impact factor: 3.473

3.  Electroencephalographic features in pediatric patients with moyamoya disease in China.

Authors:  Jia Lu; Qing Xia; Tuanfeng Yang; Jun Qiang; Xianzeng Liu; Xun Ye; Rong Wang
Journal:  Chin Neurosurg J       Date:  2020-01-13

Review 4.  Research Progress of Moyamoya Disease in Children.

Authors:  Jianmin Piao; Wei Wu; Zhongxi Yang; Jinlu Yu
Journal:  Int J Med Sci       Date:  2015-07-03       Impact factor: 3.738

5.  A Case of Hyperventilation Syndrome Mimicking Complex Partial Seizure: Usefulness of EEG Monitoring in Emergency Department.

Authors:  Bong Su Kang
Journal:  J Epilepsy Res       Date:  2015-06-30

Review 6.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.